Clinical Trials Sponsored by Abide Therapeutics
Total 6344 results
-
Verismo TherapeuticsRecruitingOvarian Cancer | Mesothelioma, Malignant | Cholangiocarcinoma RecurrentUnited States
-
APRINOIA TherapeuticsRecruitingHealthy Volunteers | Alzheimer's Disease | Mild Cognitive Impairment Due to Alzheimer's DiseaseChina
-
Dyne TherapeuticsRecruitingDuchenne Muscular Dystrophy (DMD)United States, Belgium, Canada, United Kingdom, Australia, Spain, Italy
-
Omega TherapeuticsRecruitingHepatocellular Carcinoma | Solid Tumor | Liver Cancer | Hepatocellular Carcinoma Non-resectable | Hepatocellular Cancer | Hepatocellular Carcinoma Recurrent | Liver, Cancer of, Non-ResectableUnited States, Hong Kong, Korea, Republic of, Singapore, Taiwan
-
Spero TherapeuticsRecruitingNontuberculous Mycobacterial Pulmonary Disease (NTM-PD)United States
-
Allergy TherapeuticsRecruitingPeanut AllergyUnited States
-
AUG TherapeuticsRecruitingLeukocyte Adhesion DeficiencyUnited States
-
Plus TherapeuticsNot yet recruiting
-
Lexeo TherapeuticsRecruitingAlzheimer DiseaseUnited States
-
Freeline TherapeuticsRecruitingGaucher Disease, Type 1Spain, Israel, United States, United Kingdom, Brazil, Germany, Paraguay
-
Enliven TherapeuticsRecruitingChronic Myeloid LeukemiaUnited States, Spain, France, Germany, Korea, Republic of, Australia, Canada
-
IntraGel TherapeuticsNot yet recruiting
-
Fate TherapeuticsRecruiting
-
Fulcrum TherapeuticsRecruitingSickle Cell Disease | Sickle Cell AnemiaUnited States
-
PTC TherapeuticsRecruitingPhenylketonuriaUnited States, Germany, Spain, Australia, Brazil, United Kingdom, Denmark, Mexico, Portugal, Turkey, Canada, Georgia, Italy, Netherlands, Japan
-
Karuna TherapeuticsRecruitingSchizophreniaUnited States, Serbia, Bulgaria, India, Poland, Romania, United Kingdom
-
Visus TherapeuticsRecruiting
-
Tenaya TherapeuticsRecruitingNatural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy (MyCLIMB)CardiomyopathyUnited States, Canada, United Kingdom, Spain
-
Sage TherapeuticsRecruitingHuntington's DiseaseUnited States, Australia, Canada, United Kingdom
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States
-
Faeth TherapeuticsRecruitingMetastatic Pancreatic Adenocarcinoma | Locally Advanced Unresectable Pancreatic AdenocarcinomaUnited States
-
Allogene TherapeuticsRecruitingAdvanced/Metastatic Clear Cell Renal Cell CarcinomaUnited States
-
LIDDE TherapeuticsRecruitingHemorrhagic CystitisFrance
-
Harpoon TherapeuticsRecruitingNeuroendocrine Carcinoma | Small-Cell Lung CancerUnited States
-
Allogene TherapeuticsRecruitingRelapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic LymphomaUnited States, Spain, Canada, Australia, Italy
-
Tiburio TherapeuticsNot yet recruitingNon-Functional Pituitary Adenoma | Pituitary Tumor, Nonfunctioning
-
Akcea TherapeuticsRecruitingHereditary Transthyretin Amyloidosis With PolyneuropthyUnited States, Canada
-
BioEclipse TherapeuticsRecruitingHepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Osteosarcoma | Triple Negative Breast Cancer | Epithelial Ovarian Cancer | Non-small Cell Lung Cancer | Solid Tumor, Adult | Malignant MelanomaUnited States
-
Amicus TherapeuticsRecruiting
-
Aspa TherapeuticsRecruiting
-
Effector TherapeuticsRecruitingSolid Tumor, AdultUnited States
-
Amicus TherapeuticsRecruitingPompe Disease (Late-onset)United States, Japan, Australia, Taiwan, Canada
-
Aerovate TherapeuticsActive, not recruitingPulmonary Arterial HypertensionGermany, United States, Belgium, Spain, Australia, Israel, Canada, Singapore, China, Latvia, Italy, Sweden, France, United Kingdom, Austria, Czechia, Netherlands, Poland, Mexico, Puerto Rico, Brazil, Portugal, Argentina, Chile, Greece, South...
-
PTC TherapeuticsEnrolling by invitationFriedreich AtaxiaUnited States, Australia, Brazil, Canada, France, Germany, Italy, New Zealand, Spain
-
Effector TherapeuticsTerminatedCastrate-resistant Prostate Cancer (CRPC)United States
-
PTC TherapeuticsEnrolling by invitationDuchenne Muscular DystrophyUnited States, Canada
-
PTC TherapeuticsActive, not recruitingAADC DeficiencyUnited States, Israel, Taiwan
-
Corcept TherapeuticsActive, not recruitingHypercortisolismUnited States, Austria, Bulgaria, Germany, Israel, Italy, Poland, Romania, Spain
-
Karuna TherapeuticsTerminated
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Large B Cell LymphomaUnited States, Belgium
-
MitoImmune TherapeuticsActive, not recruitingLymphoma | Multiple Myeloma | Oral Mucositis | Hematologic CancerKorea, Republic of
-
Harpoon TherapeuticsActive, not recruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma of BoneUnited States, France, Spain
-
Intellia TherapeuticsEnrolling by invitationHereditary AngioedemaFrance, New Zealand, United Kingdom, Netherlands
-
PTC TherapeuticsActive, not recruitingFriedreich AtaxiaUnited States
-
Sage TherapeuticsCompletedHuntington DiseaseUnited States
-
OrphAI TherapeuticsCompletedAcute Myeloid Leukemia | OncologyUnited States
-
Sangamo TherapeuticsActive, not recruitingHemophilia B | Mucopolysaccharidosis I | Mucopolysaccharidosis IIUnited States
-
Corcept TherapeuticsActive, not recruitingAmyotrophic Lateral SclerosisUnited States, Belgium, Canada, France, Germany, Ireland, Netherlands, Poland, Spain, United Kingdom
-
Aprea TherapeuticsCompletedAcute Myeloid Leukemia or Myelodysplastic SyndromesUnited States